Skip to Main Content

Paper Details

cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF<sup>V600E</sup> mutation.
Acta Neuropathol
140
2019
BRAFV600E, FGFR1, MYB, MYBL1, diffuse gliomas
Author NameAffiliation
David W EllisonSt. Jude Children's Research Hospital
Cynthia HawkinsThe Hospital for Sick Children
Cynthia HawkinsThe Hospital for Sick Children
David T W JonesHopp-Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
David T W JonesHopp-Children's Cancer Center Heidelberg (KiTZ)
David T W JonesGerman Cancer Research Center (DKFZ)
Stefan M PfisterHopp-Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ)
Stefan M PfisterHopp-Children's Cancer Center Heidelberg (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ)
Guido ReifenbergerInstitute of Neuropathology, Heinrich Heine University
David N LouisMassachusetts General Hospital and Harvard Medical School
  • 1 - 13

Datasets

Release 1.2